Cite
HARVARD Citation
Beyazit, F. et al. (2020). Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Medical hypotheses. p. . [Online].